Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thalidomide”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00469703
What this trial is testing

Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis

Who this might be right for
Chronic Pancreatitis
Winthrop University Hospital 10
Testing effectiveness (Phase 2)WithdrawnNCT00112879
What this trial is testing

Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma+1 more
The Cleveland Clinic
Testing effectiveness (Phase 2)Study completedNCT00310076
What this trial is testing

Thalidomide in Treating Patients Who Have Undergone Surgery and Chemotherapy for Cancer That Has Spread Throughout the Abdomen Due to Colorectal Cancer or Appendix Cancer

Who this might be right for
Carcinoma of the AppendixColorectal Cancer
Wake Forest University Health Sciences 29
Testing effectiveness (Phase 2)Study completedNCT02586038
What this trial is testing

STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS

Who this might be right for
Multiple Myeloma
Mario Boccadoro 175
Large-scale testing (Phase 3)Ended earlyNCT00005834
What this trial is testing

S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 19
Testing effectiveness (Phase 2)Study completedNCT00054158
What this trial is testing

Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT00001599
What this trial is testing

Pilot Study of Thalidomide to Treat Sjogren's Syndrome

Who this might be right for
Sjogren's SyndromeXerostomia
National Institute of Dental and Craniofacial Research (NIDCR) 28
Testing effectiveness (Phase 2)Study completedNCT00193544
What this trial is testing

Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 40
Testing effectiveness (Phase 2)Study completedNCT00777998
What this trial is testing

Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Universitätsklinikum Hamburg-Eppendorf 221
Testing effectiveness (Phase 2)Study completedNCT00040937
What this trial is testing

S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 147
Post-approval studies (Phase 4)UnknownNCT03777930
What this trial is testing

The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol

Who this might be right for
Cancer, Therapy-Related
Shenzhen Fifth People's Hospital 200
Testing effectiveness (Phase 2)UnknownNCT05198856
What this trial is testing

Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC

Who this might be right for
Gastric Cancer Metastatic to Liver
Qilu Hospital of Shandong University 106
Testing effectiveness (Phase 2)Study completedNCT00006005
What this trial is testing

Thalidomide in Treating Patients With Gynecologic Sarcomas

Who this might be right for
Endometrial CancerSarcoma
New York University Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00047294
What this trial is testing

Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT00751296
What this trial is testing

Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukaemia
University Health Network, Toronto 27
Large-scale testing (Phase 3)Ended earlyNCT00573391
What this trial is testing

Study of Multiple Myeloma Patients Relapsing or Progressing After Autologous Transplantation on Total Therapy 2

Who this might be right for
Multiple Myeloma
University of Arkansas 5
Testing effectiveness (Phase 2)Looking for participantsNCT06490627
What this trial is testing

Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia

Who this might be right for
Fetal HemoglobinThalassemia MajorGenetic Disease
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 54
Testing effectiveness (Phase 2)UnknownNCT03273452
What this trial is testing

Chidamide With PET Regimen for Angioimmunoblastic T Cell Lymphoma (PET: Prednisone, Etoposide and Thalidomide)

Who this might be right for
Angioimmunoblastic T-cell Lymphoma
Qingdao University 30
Testing effectiveness (Phase 2)Study completedNCT00027638
What this trial is testing

Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorLung Cancer+1 more
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)Active Not RecruitingNCT00098475
What this trial is testing

Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma

Who this might be right for
DS Stage I Multiple MyelomaDS Stage II Multiple MyelomaDS Stage III Multiple Myeloma
National Cancer Institute (NCI) 452
Next Page